在测试集中，灵敏度为88%，特异性为84%。此外，Exact Sciences还表示，他们在《当前医学研究与意见》上发表了一篇题为“Patterns of initial colorectal cancer screenings after turning 50 years old and follow-up rates of colonoscopy after positive stool-based testing among the average-risk population的文章，...
Now that you have your Cologuard test, learn how to use it for colon cancer screening and understand your test results. Get instructions Enhanced accuracy. Same ease of use. With advancements in cancer detection and false positive rates, the new Cologuard Plus™ test offers the latest innovatio...
Now that you have your Cologuard test, learn how to use it for colon cancer screening and understand your test results. Get instructions Enhanced accuracy. Same ease of use. With advancements in cancer detection and false positive rates, the new Cologuard Plus™ test offers the latest innovatio...
Now that you have your Cologuard test, learn how to use it for colon cancer screening and understand your test results. Get instructions Enhanced accuracy. Same ease of use. With advancements in cancer detection and false positive rates, the new Cologuard Plus™ test offers the latest innovatio...
Now that you have your Cologuard test, learn how to use it for colon cancer screening and understand your test results. Get instructions Enhanced accuracy. Same ease of use. With advancements in cancer detection and false positive rates, the new Cologuard Plus™ test offers the latest innovatio...
With advancements in cancer detection and false positive rates, the new Cologuard Plus™ test offers the latest innovation from Exact Sciences.1,3 Learn more Screen for Colon Cancer in the Privacy of Your Home The Cologuard test is for adults 45+ at average risk. It’s a noninvasive and...
Edwards DK. Estimating the screening-eligible population size, aged 45 to 74, at average risk to develop colorectal cancer in the United States.Cancer Prev Res.2020;13(5):443-448. *Estimate based on the US population aged 45-74 as of 2018, adjusted f...
The majority of those with positive results, the researchers explained, will be false positives due to the low prevalence of cancer. The false positive rates for FIT were 3.6% to 5.1% versus 10.2% to 13.4% with Cologuard. Among those with a negative colonoscopy result, the DNA test’s spec...
“By decreasing false positives, it reduces the number of patients who have to undergo a follow-up invasive procedure. In a similar vein, it reduces the number of patients who had a positive Cologuard, then underwent a colonoscopy where nothing was found and are left feeling worried that somet...